About the Authors
- Andrew T. Miller
-
* E-mail: amiller@gnf.org
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Carol Dahlberg
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Mark L. Sandberg
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Ben G. Wen
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Daniel R. Beisner
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- John A. H. Hoerter
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Albert Parker
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Christian Schmedt
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Monique Stinson
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Jacqueline Avis
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Cynthia Cienfuegos
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Mark McPate
-
Affiliation Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom
- Pamela Tranter
-
Affiliation Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom
- Martin Gosling
-
Affiliation Novartis Pharmaceuticals UK Limited, Respiratory Disease Area, Horsham, West Sussex, United Kingdom
- Paul J. Groot-Kormelink
-
Affiliation Novartis Institutes for Biomedical Research, Musculoskeletal Disease Area, Basel, Switzerland
- Janet Dawson
-
Affiliation Novartis Pharma AG, Novartis Institutes for Biomed. Research, Basel, Switzerland
- Shifeng Pan
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Shin-Shay Tian
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- H. Martin Seidel
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
- Michael P. Cooke
-
Affiliation The Genomics Institute of the Novartis Research Foundation (GNF), San Diego, California, United States of America
Competing Interests
All work was funded by the Novartis Institutes for Biomedical Research. All authors are employed by either Novartis Research Foundation (GNF), Novartis Pharmaceuticals UK Limited, Novartis Institutes for Biomedical Research and Novartis Pharma AG. There are no products in development or marketed products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: ATM MLS BGW DRB PT PJGK JD MPC. Performed the experiments: CD MLS DRB JAH AP CS MS MM JA CC. Analyzed the data: ATM CD MLS BGW DRB JAH AP CS MS MM PT MG PJGK JD SP SST HMS MPC. Wrote the paper: ATM MPC.